Noninvasive urinary metabonomic diagnosis of human bladder cancer

Journal of Proteome Research

Volumn 9, Issue 6, 2010, Pages 2988-2995

  Pasikanti, Kishore Kumar ^a   Esuvaranathan, Kesavan ^b   Ho, Paul C ^a   Mahendran, Ratha ^b   Kamaraj, Revathi ^b   Wu, Qing Hui ^b   Chiong, Edmund ^b   Chan, Eric Chun Yong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

bladder cancer; diagnosis; gas chromatography mass spectrometry; metabolic profiling; metabolomics; metabonomics

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS; URINE CYTOLOGY;

CASE-CONTROL STUDIES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HISTOCYTOCHEMISTRY; HUMANS; LEAST-SQUARES ANALYSIS; METABOLOME; METABOLOMICS; NEOPLASM STAGING; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77954606504     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr901173v     Document Type: Article

References (50)

1. Kitamura, H.; Tsukamoto, T. Early bladder cancer: concept, diagnosis, and management. Int. J. Clin. Oncol. 2006, 11 (1), 28-37.
2. Botteman, M. F.; Pashos, C. L.; Redaelli, A.; Laskin, B.; Hauser, R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003, 21 (18), 1315-1330
3. Chiong, E.; Gaston, K. E.; Grossman, H. B. Urinary markers in screening patients with hematuria. World J. Urol. 2008, 26 (1), 25-30.
4. Glatz, K.; Willi, N.; Glatz, D.; Barascud, A.; Grilli, B.; Herzog, M.; Dalquen, P.; Feichter, G.; Gasser, T. C.; Sulser, T.; Bubendorf, L. An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system. Am. J. Clin. Pathol. 2006, 126 (2), 294-301.
5. Leyh, H.; Marberger, M.; Conort, P.; Sternberg, C.; Pansadoro, V.; Pagano, F.; Bassi, P.; Boccon-Gibod, L.; Ravery, V.; Treiber, U.; Ishak, L. Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer. Eur. Urol. 1999, 35 (1), 52-56
6. Planz, B.; Jochims, E.; Deix, T.; Caspers, H. P.; Jakse, G.; Boecking, A. The role of urinary cytology for detection of bladder cancer. Eur. J. Surg. Oncol. 2005, 31 (3), 304-308
7. Toma, M. I.; Friedrich, M. G.; Hautmann, S. H.; Jakel, K. T.; Erbersdobler, A.; Hellstern, A.; Huland, H. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. World J. Urol. 2004, 22 (2), 145-149
8. Knowles, M. A. Molecular pathogenesis of bladder cancer. Int. J. Clin. Oncol. 2008, 13 (4), 287-297
9. Lacy, S.; Lopez-Beltran, A.; MacLennan, G. T.; Foster, S. R.; Montironi, R.; Cheng, L. Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. Anal. Quant. Cytol. Histol. 2009, 31 (1), 5-16.
10. Mitra, A. P.; Cote, R. J. Molecular screening for bladder cancer: progress and potential. Nat. Rev. Urol. 2010, 7 (1), 11-20.
11. Mitra, A. P.; Datar, R. H.; Cote, R. J. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J. Clin. Oncol. 2006, 24 (35), 5552-5564
12. Willis, C. M.; Church, S. M.; Guest, C. M.; Cook, W. A.; McCarthy, N.; Bransbury, A. J.; Church, M. R.; Church, J. C. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ 2004, 329 (7468), 712.
13. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457 (7231), 910-914
14. Spratlin, J. L.; Serkova, N. J.; Eckhardt, S. G. Clinical applications of metabolomics in oncology: a review. Clin. Cancer Res. 2009, 15 (2), 431-440
15. Lewis, G. D.; Wei, R.; Liu, E.; Yang, E.; Shi, X.; Martinovic, M.; Farrell, L.; Asnani, A.; Cyrille, M.; Ramanathan, A.; Shaham, O.; Berriz, G.; Lowry, P. A.; Palacios, I. F.; Tasan, M.; Roth, F. P.; Min, J.; Baumgartner, C.; Keshishian, H.; Addona, T.; Mootha, V. K.; Rosenzweig, A.; Carr, S. A.; Fifer, M. A.; Sabatine, M. S.; Gerszten, R. E. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J. Clin. Invest. 2008, 118 (10), 3503-3512
16. Hirayama, A.; Kami, K.; Sugimoto, M.; Sugawara, M.; Toki, N.; Onozuka, H.; Kinoshita, T.; Saito, N.; Ochiai, A.; Tomita, M.; Esumi, H.; Soga, T. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009, 69 (11), 4918-4925
17. Vinayavekhin, N.; Homan, E. A.; Saghatelian, A. Exploring disease through metabolomics. ACS Chem. Biol. 2010, 5 (1), 91-103.
18. Nordstrom, A.; Lewensohn, R. Metabolomics: moving to the clinic. J. Neuroimmune Pharmacol. 2010, 5 (1), 4-17.
19. Keun, H. C. Metabonomic modeling of drug toxicity. Pharmacol Ther. 2006, 109 (1-2), 92-106.
20. Claudino, W. M.; Quattrone, A.; Biganzoli, L.; Pestrin, M.; Bertini, I.; Di Leo, A. Metabolomics: available results, current research projects in breast cancer, and future applications. J. Clin. Oncol. 2007, 25 (19), 2840-2846
21. Issaq, H. J.; Nativ, O.; Waybright, T.; Luke, B.; Veenstra, T. D.; Issaq, E. J.; Kravstov, A.; Mullerad, M. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry. J. Urol. 2008, 179 (6), 2422-2426
22. Lenz, E. M.; Wilson, I. D. Analytical strategies in metabonomics. J. Proteome Res. 2007, 6 (2), 443-458
23. Pasikanti, K. K.; Ho, P. C.; Chan, E. C. Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. J. Chromatogr., B: Analyt. Technol. Biomed. Life Sci. 2008, 871 (2), 202-211
24. Want, E. J.; Nordstrom, A.; Morita, H.; Siuzdak, G. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J. Proteome Res. 2007, 6 (2), 459-468
25. Halket, J. M.; Waterman, D.; Przyborowska, A. M.; Patel, R. K.; Fraser, P. D.; Bramley, P. M. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J. Exp. Bot. 2005, 56 (410), 219-243
26. Pasikanti, K. K.; Ho, P. C.; Chan, E. C. Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites. Rapid Commun. Mass Spectrom. 2008, 22 (19), 2984-2992
27. Bao, Y.; Zhao, T.; Wang, X.; Qiu, Y.; Su, M.; Jia, W. Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. J. Proteome Res. 2009, 8 (4), 1623-1630
28. Li, X.; Xu, Z.; Lu, X.; Yang, X.; Yin, P.; Kong, H.; Yu, Y.; Xu, G. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus. Anal. Chim. Acta 2009, 633 (2), 257-262
29. Wu, H.; Xue, R.; Dong, L.; Liu, T.; Deng, C.; Zeng, H.; Shen, X. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal. Chim. Acta 2009, 648 (1), 98-104.
30. Kind, T.; Tolstikov, V.; Fiehn, O.; Weiss, R. H. A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal. Biochem. 2007, 363 (2), 185-195
31. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A.; Xu, L. X.; Cai, S.; Jia, W. Serum Metabolite Profiling of Human Colorectal Cancer Using GC/TOFMS and UPLC-QTOFMS. J. Proteome Res. 2009, 8, 4844-4850
32. Denkert, C.; Budczies, J.; Kind, T.; Weichert, W.; Tablack, P.; Sehouli, J.; Niesporek, S.; Konsgen, D.; Dietel, M.; Fiehn, O. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006, 66 (22), 10795-10804
33. Vallejo, M.; Garcia, A.; Tunon, J.; Garcia-Martinez, D.; Angulo, S.; Martin-Ventura, J. L.; Blanco-Colio, L. M.; Almeida, P.; Egido, J.; Barbas, C. Plasma fingerprinting with GC/MS in acute coronary syndrome. Anal. Bioanal. Chem. 2009, 394 (6), 1517-1524
34. Lin, H. M.; Edmunds, S. I.; Helsby, N. A.; Ferguson, L. R.; Rowan, D. D. Nontargeted urinary metabolite profiling of a mouse model of Crohn's disease. J. Proteome Res. 2009, 8 (4), 2045-2057
35. Epstein, J. I.; Amin, M. B.; Reuter, V. R.; Mostofi, F. K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 1998, 22 (12), 1435-1448
36. Gorgenyi, M.; Fekete, Z. A.; Van Langenhove, H.; Dewulf, J. Temperature dependence of the Kovats retention index. Convex or concave curves. J. Chromatogr., A 2008, 1206 (2), 178-185
37. Xia, J.; Psychogios, N.; Young, N.; Wishart, D. S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009, 37 (Web Server issue), W652-60.
38. Warrack, B. M.; Hnatyshyn, S.; Ott, K. H.; Reily, M. D.; Sanders, M.; Zhang, H.; Drexler, D. M. Normalization strategies for metabonomic analysis of urine samples. J. Chromatogr., B: Analyt. Technol. Biomed. Life Sci. 2009, 877 (5-6), 547-552
39. Trygg, J.; Holmes, E.; Lundstedt, T. Chemometrics in metabonomics. J. Proteome Res. 2007, 6 (2), 469-479
40. van den Berg, R. A.; Hoefsloot, H. C.; Westerhuis, J. A.; Smilde, A. K.; van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006, 7, 142.
41. Bylesjo, M.; Eriksson, D.; Kusano, M.; Moritz, T.; Trygg, J. Data integration in plant biology: the O2PLS method for combined modeling of transcript and metabolite data. Plant J. 2007, 52 (6), 1181-1191
42. Wiklund, S.; Nilsson, D.; Eriksson, L.; Sjostrom, M.; Wold, S.; Faber, K. A randomization test for PLS component selection. J. Chemom. 2007, 21 (10-11), 427-439.
43. Mahadevan, S.; Shah, S. L.; Marrie, T. J.; Slupsky, C. M. Analysis of metabolomic data using support vector machines. Anal. Chem. 2008, 80 (19), 7562-7570
44. Linden, A. Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J. Eval. Clin. Pract. 2006, 12 (2), 132-139
45. Cserhati, T.; Kosa, A.; Balogh, S. Comparison of partial least-square method and canonical correlation analysis in a quantitative structure-retention relationship study. J. Biochem. Biophys. Methods 1998, 36 (2-3), 131-141
46. Wiklund, S.; Johansson, E.; Sjostrom, L.; Mellerowicz, E. J.; Edlund, U.; Shockcor, J. P.; Gottfries, J.; Moritz, T.; Trygg, J. Visualization of GC/TOF-MS-Based Metabolomics Data for Identification of Biochemically Interesting Compounds Using OPLS Class Models. Anal. Chem. 2008, 80 (1), 115-122.
47. Gika, H. G.; Theodoridis, G. A.; Wingate, J. E.; Wilson, I. D. Withinday reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J. Proteome Res. 2007, 6 (8), 3291-3303
48. Holmes, E.; Antti, H. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst 2002, 127 (12), 1549-1557
49. Lokeshwar, V. B.; Habuchi, T.; Grossman, H. B.; Murphy, W. M.; Hautmann, S. H.; Hemstreet, G. P., 3rd; Bono, A. V.; Getzenberg, R. H.; Goebell, P.; Schmitz-Drager, B. J.; Schalken, J. A.; Fradet, Y.; Marberger, M.; Messing, E.; Droller, M. J. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology 2005, 66 (6 Suppl 1), 35-63. (Pubitemid 43049608)
50. Lopez-Beltran, A.; Cheng, L. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. Pathology 2003, 35 (6), 484-491